What is Agios Pharmaceuticals's capex?

Agios Pharmaceuticals (AGIO) reported capex of $769K in Q1 2026.

How has Agios Pharmaceuticals's capex changed year-over-year?

Agios Pharmaceuticals's capex increased by 0.4% year-over-year, from $766K to $769K.

What is the long-term trend for Agios Pharmaceuticals's capex?

Over 4 years (2021 to 2025), Agios Pharmaceuticals's capex has grown at a -7.0% compound annual growth rate (CAGR), from $5.76M to $4.32M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Agios Pharmaceuticals AGIO CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

PfizerPFE

$436M-22.7%

Vertex PharmaceuticalsVRTX

$133.4M+228%

BioMarin PharmaceuticalsBMRN

$20.92M+24.8%

Disc MedicineIRON

$0-100%

IncyteINCY

——

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's capex?: Agios Pharmaceuticals (AGIO) reported capex of $769K in Q1 2026.
How has Agios Pharmaceuticals's capex changed year-over-year?: Agios Pharmaceuticals's capex increased by 0.4% year-over-year, from $766K to $769K.
What is the long-term trend for Agios Pharmaceuticals's capex?: Over 4 years (2021 to 2025), Agios Pharmaceuticals's capex has grown at a -7.0% compound annual growth rate (CAGR), from $5.76M to $4.32M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.